Related Experiment Video
Updated: Apr 26, 2026
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
The cost of absenteeism and short-term disability associated with colorectal cancer: a case-control study
Avin Yaldo1, Brian S Seal, Maureen J Lage
1From Bayer HealthCare Pharmaceuticals, Inc (Drs Yaldo and Seal), Wayne, NJ; and HealthMetrics Outcomes Research, LLC (Dr Lage), Bonita Springs, Fla.
Objective:
Examine the incremental impact of absenteeism and short-term disability associated with colorectal cancer (CRC).
Methods:
Absenteeism and short-term disability data were used for a case-control analysis of a healthy cohort (controls) compared with CRC patients (cases). Cases were matched to controls on the basis of age, sex, and region of residence. Multivariate regression models examined the costs of absenteeism and short-term disability, controlling for patient characteristics, prior medical costs, and patient general health.
Results:
Compared with controls, CRC patients experience significantly higher short-term disability costs (mean, $45,716 vs $7367 [P < 0.0001]; median, $35,827 vs $7365 [P < 0.0001]), as well as significantly higher absenteeism costs (mean, $8841 vs $4596 [P < 0.0001]; median, $9971 vs $4795 [P < 0.0001]) in the 1 year after diagnosis of CRC.
Conclusions:
Colorectal cancer is associated with significant work-related productivity loss costs in the first year after diagnosis.
